journal
Journals Ontario Health Technology Asse...

Ontario Health Technology Assessment Series

https://read.qxmd.com/read/34422143/istent-for-adults-with-glaucoma-a-health-technology-assessment
#21
JOURNAL ARTICLE
(no author information available yet)
Background: Glaucoma is a condition that causes progressive damage to the optic nerve, which can lead to visual impairment and potentially to irreversible blindness. The iStent and iStent inject are devices implanted in the eye during a type of minimally invasive glaucoma surgery (MIGS) to reduce intraocular pressure by increasing trabecular outflow by bypassing the trabecular meshwork. We summarized two health technology assessments and additional recent publications that evaluated iStent for people with glaucoma, including effectiveness, safety, cost-effectiveness, the budget impact of publicly funding iStent, and patient preferences and values...
2021: Ontario Health Technology Assessment Series
https://read.qxmd.com/read/34211617/nonthermal-endovenous-procedures-for-varicose-veins-a-health-technology-assessment
#22
JOURNAL ARTICLE
(no author information available yet)
BACKGROUND: Varicose veins are part of the spectrum of chronic venous disease and are a sign of underlying chronic venous insufficiency. Treatments to address varicose veins include surgical vein removal under general anesthesia, or endovenous laser (EVLA) or radiofrequency ablation (RFA) under tumescent anesthesia. Two newer nonthermal endovenous procedures can close veins without any tumescent anesthesia, using either mechanochemical ablation (MOCA, a combination of mechanical and chemical techniques) or cyanoacrylate adhesive closure (CAC)...
2021: Ontario Health Technology Assessment Series
https://read.qxmd.com/read/34211616/skin-substitutes-for-adults-with-diabetic-foot-ulcers-and-venous-leg-ulcers-a-health-technology-assessment
#23
JOURNAL ARTICLE
(no author information available yet)
Background: Wounds may be caused in a variety of ways. Some wounds are difficult to heal, such as diabetic foot ulcers and venous leg ulcers. We conducted a health technology assessment of skin substitutes for adults with neuropathic diabetic foot ulcers and venous leg ulcers, which included an evaluation of effectiveness, safety, cost-effectiveness, the budget impact of publicly funding skin substitutes, and patient preferences and values. Methods: We performed a systematic literature search of the clinical evidence...
2021: Ontario Health Technology Assessment Series
https://read.qxmd.com/read/34188733/prostatic-artery-embolization-for-benign-prostatic-hyperplasia-a-health-technology-assessment
#24
JOURNAL ARTICLE
(no author information available yet)
BACKGROUND: Benign prostatic hyperplasia (BPH) is a noncancerous enlargement of the prostate that commonly affects older people with prostates and may lead to obstructive urinary symptoms. Symptoms may initially be mild but tend to worsen over time. Prostatic artery embolization (PAE) is an endovascular procedure to treat BPH, wherein an interventional radiologist inserts a catheter into the patient to inject tiny particles intended to reduce blood flow to the enlarged prostate, causing it to shrink in size...
2021: Ontario Health Technology Assessment Series
https://read.qxmd.com/read/34188732/pigmented-lesion-assay-for-suspected-melanoma-lesions-a-health-technology-assessment
#25
JOURNAL ARTICLE
(no author information available yet)
Background: Early detection of melanoma is key, as survival rates are substantially better when the cancer is detected in its early stages. Currently, the standard of care is to biopsy any lesion suspected of melanoma for diagnostic confirmation by histopathology. As a result, most people who undergo biopsy receive negative melanoma results. If effective, a non-invasive alternative, such as pigmented lesion assay, could minimize the number of unnecessary biopsies performed. We conducted a health technology assessment of pigmented lesion assay for people with suspected melanoma lesions, which included an evaluation of diagnostic accuracy, clinical utility, the budget impact of publicly funding pigmented lesion assay, and the preferences and values of people who have undergone biopsy for suspected melanoma...
2021: Ontario Health Technology Assessment Series
https://read.qxmd.com/read/34055112/repetitive-transcranial-magnetic-stimulation-for-people-with-treatment-resistant-depression-a-health-technology-assessment
#26
JOURNAL ARTICLE
(no author information available yet)
Background: Major depression is one of the most diagnosed mental illnesses in Canada. Generally, people are treated successfully with antidepressants or psychotherapy, but some people do not respond to these treatments (called treatment-resistant depression [TRD]). Repetitive transcranial magnetic stimulation (rTMS) delivers magnetic pulses to stimulate the areas of the brain associated with mood regulation. Several modalities of rTMS exist (e.g., high frequency rTMS, intermittent theta burst stimulation [iTBS], deep transcranial magnetic stimulation)...
2021: Ontario Health Technology Assessment Series
https://read.qxmd.com/read/34055111/vaginal-pessaries-for-pelvic-organ-prolapse-or-stress-urinary-incontinence-a-health-technology-assessment
#27
JOURNAL ARTICLE
(no author information available yet)
Background: Pelvic organ prolapse (POP) is the downward descent of the female pelvic organs into or through the vagina. The symptom that most strongly correlates with and is most specific for POP is a feeling of vaginal bulging. Stress urinary incontinence (SUI) is an involuntary loss of urine upon physical exertion or sneezing or coughing. Conservative (non-surgical) treatment options for both conditions include vaginal pessaries. We conducted a health technology assessment of vaginal pessaries for the treatment of POP and SUI, which included an evaluation of effectiveness, safety, cost-effectiveness, the budget impact of publicly funding vaginal pessaries, and patient preferences and values...
2021: Ontario Health Technology Assessment Series
https://read.qxmd.com/read/34055110/use-of-b-type-natriuretic-peptide-bnp-and-n-terminal-probnp-nt-probnp-as-diagnostic-tests-in-adults-with-suspected-heart-failure-a-health-technology-assessment
#28
JOURNAL ARTICLE
(no author information available yet)
Background: Heart failure is a complex clinical syndrome that usually presents with breathlessness, leg edema, and fatigue. Clinically measurable natriuretic neurohormones such as B-type natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) are elevated in people with heart failure. We conducted a health technology assessment of BNP and NT-proBNP tests for people with suspected heart failure, which included an evaluation of diagnostic accuracy, clinical impact, cost-effectiveness, the budget impact of publicly funding BNP and NT-proBNP tests, and patient preferences and values...
2021: Ontario Health Technology Assessment Series
https://read.qxmd.com/read/34055109/proton-beam-therapy-for-cancer-in-children-and-adults-a-health-technology-assessment
#29
JOURNAL ARTICLE
(no author information available yet)
Background: Proton beam therapy has potential to reduce late toxicity in cancer treatment by reducing the risk of damage to surrounding healthy tissues. We conducted a health technology assessment of proton beam therapy, compared with photon therapy, for children and adults with cancer requiring radiotherapy. Our assessment included an evaluation of safety, effectiveness, cost-effectiveness, the budget impact of publicly funding the construction and use of proton beam therapy in Ontario, and patient preferences and values...
2021: Ontario Health Technology Assessment Series
https://read.qxmd.com/read/35136462/transcatheter-valve-in-valve-implantation-for-degenerated-mitral-or-tricuspid-bioprosthetic-valves-a-heath-technology-assessment
#30
JOURNAL ARTICLE
(no author information available yet)
Background: Bioprosthetic valves used to treat mitral or tricuspid valve disease can be expected to deteriorate and eventually fail after 10 to 15 years. For patients who are considered inoperable or high-risk for surgery, medical management (i.e., drug therapy, the current standard of care in Ontario) does not significantly alter the course of valvular heart disease or improve degenerated bioprosthetic valves. An alternative for these patients is transcatheter mitral or tricuspid valve-in-valve implantation (TMViV or TTViV)...
2020: Ontario Health Technology Assessment Series
https://read.qxmd.com/read/33240456/noninvasive-fetal-rhd-blood-group-genotyping-a-health-technology-assessment
#31
JOURNAL ARTICLE
(no author information available yet)
Background: RhD blood group incompatibility during pregnancy can cause serious health problems for the fetus. Noninvasive fetal RhD blood group genotyping is a test for fetal RhD status that may help prevent unnecessary preventive treatment (Rh immunoglobulin [RhIG] injections) and intensive pregnancy monitoring. We conducted a health technology assessment of noninvasive fetal RhD blood group genotyping for RhD-negative (RhD-) pregnancies. Our assessment evaluated the test's diagnostic accuracy, clinical utility, and cost-effectiveness, the budget impact of publicly funding this test, and patients' and providers' preferences and values...
2020: Ontario Health Technology Assessment Series
https://read.qxmd.com/read/33240455/transcatheter-aortic-valve-implantation-in-patients-with-severe-aortic-valve-stenosis-at-low-surgical-risk-a-health-technology-assessment
#32
JOURNAL ARTICLE
(no author information available yet)
Background: Surgical aortic valve replacement (SAVR) is the conventional treatment for patients with severe aortic valve stenosis at low surgical risk. Transcatheter aortic valve implantation (TAVI) is a less invasive procedure. We conducted a health technology assessment (HTA) of TAVI for patients with severe aortic valve stenosis at low surgical risk, which included an evaluation of effectiveness, safety, cost-effectiveness, the budget impact of publicly funding TAVI, and patient preferences and values...
2020: Ontario Health Technology Assessment Series
https://read.qxmd.com/read/33240454/automated-ct-perfusion-imaging-to-aid-in-the-selection-of-patients-with-acute-ischemic-stroke-for-mechanical-thrombectomy-a-health-technology-assessment
#33
JOURNAL ARTICLE
(no author information available yet)
Background: Stroke is a sudden interruption in the blood supply to a part of the brain, causing loss of neurological function. It is the third leading cause of death in Canada and affects mainly older people. In the acute setting, neuroimaging is integral to stroke evaluation and decision-making. The neuroimaging results guide patient selection for mechanical thrombectomy. Using automated image processing techniques facilitates efficient review of this information and communication between centres...
2020: Ontario Health Technology Assessment Series
https://read.qxmd.com/read/33240453/home-narrowband-ultraviolet-b-phototherapy-for-photoresponsive-skin-conditions-a-health-technology-assessment
#34
JOURNAL ARTICLE
(no author information available yet)
Background: Skin conditions are photoresponsive if they respond to ultraviolet (UV) radiation with partial or complete clearing. Ultraviolet phototherapy is performed by exposing the skin to UV radiation on a regular basis under medical supervision. Three types of UV radiation are used to treat photoresponsive skin conditions: broadband ultraviolet B (BB-UVB), psoralen plus ultraviolet A (PUVA), and narrowband ultraviolet B (NB-UVB). Narrowband UVB phototherapy is generally more effective than BB-UVB and safer than PUVA in the management of several photoresponsive skin conditions...
2020: Ontario Health Technology Assessment Series
https://read.qxmd.com/read/32284771/extracorporeal-membrane-oxygenation-for-cardiac-indications-in-adults-a-health-technology-assessment
#35
JOURNAL ARTICLE
(no author information available yet)
Background: Extracorporeal membrane oxygenation (ECMO) is a rescue therapy used to stabilize patients with hemodynamic compromise such as refractory cardiogenic shock or cardiac arrest. When used for cardiac arrest, ECMO is also known as extracorporeal cardiopulmonary resuscitation (ECPR). We conducted a health technology assessment of venoarterial ECMO for adults (aged ≥ 18 years) with cardiac arrest refractory to conventional cardiopulmonary resuscitation (CPR) or with cardiogenic shock refractory to conventional medical management (i...
2020: Ontario Health Technology Assessment Series
https://read.qxmd.com/read/32284770/gene-expression-profiling-tests-for-early-stage-invasive-breast-cancer-a-health-technology-assessment
#36
JOURNAL ARTICLE
(no author information available yet)
Background: Breast cancer is a disease in which cells in the breast grow out of control. They often form a tumour that may be seen on an x-ray or felt as a lump.Gene expression profiling (GEP) tests are intended to help predict the risk of metastasis (spread of the cancer to other parts of the body) and to identify people who will most likely benefit from chemotherapy. We conducted a health technology assessment of four GEP tests (EndoPredict, MammaPrint, Oncotype DX, and Prosigna) for people with early-stage invasive breast cancer, which included an evaluation of effectiveness, safety, cost effectiveness, the budget impact of publicly funding GEP tests, and patient preferences and values...
2020: Ontario Health Technology Assessment Series
https://read.qxmd.com/read/32206157/cell-free-circulating-tumour-dna-blood-testing-to-detect-egfr-t790m-mutation-in-people-with-advanced-non-small-cell-lung-cancer-a-health-technology-assessment
#37
JOURNAL ARTICLE
(no author information available yet)
Background: Cell-free circulating tumour DNA blood testing (also called liquid biopsy) can determine if a person with advanced non-small cell lung cancer (NSCLC) whose disease is progressing has developed the epidermal growth factor receptor ( EGFR ) T790M resistance mutation. Identifying this resistance mutation can help physicians choose appropriate treatment (i.e., osimertinib if positive and chemotherapy if negative). Tissue biopsy is typically used to look for the resistance mutation, but this is an invasive test that might not be feasible if the patient is too ill...
2020: Ontario Health Technology Assessment Series
https://read.qxmd.com/read/32194883/5-aminolevulinic-acid-hydrochloride-5-ala-guided-surgical-resection-of-high-grade-gliomas-a-health-technology-assessment
#38
JOURNAL ARTICLE
(no author information available yet)
BACKGROUND: High-grade gliomas are a type of malignant brain tumour. Optimal management often includes maximal surgical resection. 5-aminolevulinic acid hydrochloride (5-ALA) is an imaging agent that makes a high-grade glioma fluoresce under blue light, which can help guide the surgeon when removing the tumour. We conducted a health technology assessment of 5-ALA-guided surgical resection of high-grade gliomas, which included an evaluation of effectiveness, safety, the budget impact of publicly funding 5-ALA, and patient preferences and values...
2020: Ontario Health Technology Assessment Series
https://read.qxmd.com/read/32194882/continual-long-term-physiotherapy-after-stroke-a-health-technology-assessment
#39
JOURNAL ARTICLE
(no author information available yet)
Background: Stroke is a serious health issue in which an interruption in blood flow to any part of the brain damages brain cells. About 83% of people survive with substantial morbidity after their first stroke. We conducted a health technology assessment of continual long-term physiotherapy for people with a diagnosis of stroke, which included an evaluation of effectiveness, safety, cost-effectiveness, the budget impact of publicly funding continual long-term physiotherapy for people with a diagnosis of stroke, and patient preferences and values...
2020: Ontario Health Technology Assessment Series
https://read.qxmd.com/read/32194881/10-khz-high-frequency-spinal-cord-stimulation-for-adults-with-chronic-noncancer-pain-a-health-technology-assessment
#40
JOURNAL ARTICLE
(no author information available yet)
Background: Chronic pain is costly for patients and for the health care system. It negatively affects people's physical, emotional, social, and mental health. We conducted a health technology assessment of 10-kHz high-frequency spinal cord stimulation (SCS) in adults with chronic noncancer pain that was refractory to medical management, which included an evaluation of effectiveness, safety, cost-effectiveness, the budget impact of publicly funding 10-kHz high-frequency SCS, and patient preferences and values...
2020: Ontario Health Technology Assessment Series
journal
journal
42808
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.